Skip to content
akaturk Academic measurement

Article detail · 2022 · article

Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c \u2018hydrocortisone-polarised\u2019 macrophages

ISSN0301-4851
YÖKSİS OpenAlex
Year2022
Citations14OpenAlex
Citations12Semantic Scholar
Percentile%68.4
FWCI0.861.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueMolecular Biology Reports
  • Catalog match (ISSN)Molecular Biology Reports
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

14citationsOpenAlex · cited_by_count (cache / database)

19 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsCitations 19 · OpenAlex
  2. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsCitations 19 · OpenAlex
  3. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsCitations 19 · OpenAlex
  4. 2025 Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 PathwayCitations 9 · OpenAlex
  5. 2025 Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 PathwayCitations 8 · OpenAlex
  6. 2025 Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 PathwayCitations 8 · OpenAlex
  7. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Citations 5 · OpenAlex
  8. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Citations 5 · OpenAlex
  9. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Citations 5 · OpenAlex
  10. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Citations 5 · OpenAlex

Authors

2
  1. SELİN ENGÜR ÖZTÜRK PAMUKKALE ÜNİVERSİTESİ 1
  2. MİRİŞ DİKMEN 2